Opus Genetics, Inc. (IRD) dividend history

IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30460% above fair value

$3.98−0.08 (-1.97%)

Close on Nov 13, 2026Market cap $331.12MP/E –Yield –

Dividends

No dividend per share appears in Opus Genetics's annual filings since fiscal 2010.

Parsed from the XBRL in Opus Genetics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Nov 6, 2020
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IRD.

Revenue growth-45.9% · median -93.5%

Operating margin-777.7% · median -2652.8%

Net margin-1726.7% · median -2606.4%

Advertisement
300 × 250

See a number that looks wrong?